Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference GlobeNewswire January 07, 2026 WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and […]

(NASDAQ:DEFT), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the “Class Period”), of the important January 30, 2026 lead plaintiff deadline. SO WHAT: If

(NASDAQ:PHAT), FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025. Preliminary Fourth Quarter 2025 Financial Results For the

(NASDAQ:GLUE), BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and, in lieu of common stock to certain investors,

(NASDAQ:FANG), MIDLAND, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2025 financial results on February 23, 2026 after the market closes. In connection with the earnings release, Diamondback will host a conference call and webcast for investors and analysts to discuss

(NASDAQ:VNOM), MIDLAND, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2025 financial results on February 23, 2026 after the market closes. In connection with the earnings release, Viper will host a conference

(NASDAQ:GNLX), WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common stock. In addition, Genelux expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the

(NASDAQ:KNSA), LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time). A live webcast of Kiniksa's presentation will be accessible through the Investors section

ROSEN, A LEADING LAW FIRM, Encourages DeFi Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DEFT GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire January 07, 2026 FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited financial results for the fourth quarter